Wang Xiaochuan, Zhao Yining, Zhao Youquan, Li Minglei, Zhao Fangzhou, Yang Boyu, Quan Hui, Zhao Sujuan, Tian Ye, Geng Hongquan, Li Jun
Department of Urology, Beijing Friendship Hospital, Capital Medical University, China.
Institute of Urology, Beijing Municipal Health Commission, China.
Kidney Int Rep. 2025 May 1;10(8):2789-2799. doi: 10.1016/j.ekir.2025.04.056. eCollection 2025 Aug.
The incidence of pediatric nephrolithiasis has been increasing, and the role of genetic factors has garnered attention in recent years. This study aimed to explore the genetic basis underlying pediatric nephrolithiasis in Chinese population.
Whole exome sequencing (WES) was conducted in a consecutive cohort of 456 children over a 11-year period. Clinical and genetic data were systematically collected, analyzed, and comprehensively compared.
Average age was 4.2 years with a male-to-female ratio of 2.2. A total of 260 causative variants in 16 genes were identified in 141 children, resulting in a positive molecular diagnosis rate of 31%. Of the causative variants, 43% were novel. The most prevalent diagnoses were primary hyperoxaluria (PH) (: 20%, : 11%, and : 24%) and cystinuria (: 18% and : 14%). Children with positive molecular diagnoses were more likely to have stone episodes, bilateral stones, multiple stones, or nephrocalcinosis (all < 0.05). Children with defects were more prone to have severe clinical manifestations, and those with defects and males with and defects tended to be diagnosed at a younger age. The concordance rate between suspected clinical diagnoses and molecular diagnoses was 81%. At least 29% of children could benefit from additional clinical advice based on a molecular diagnosis.
A genetic etiology was identified in 141 of 456 of pediatric patients (31%) with nephrolithiasis in a Chinese cohort. A positive molecular diagnosis is a risk factor for severe clinical presentation of pediatric nephrolithiasis. WES has the potential to be used to confirm or even modify clinical diagnoses, thereby facilitating individualized therapeutic and preventive interventions.
儿童肾结石的发病率一直在上升,近年来遗传因素的作用受到了关注。本研究旨在探讨中国人群儿童肾结石的遗传基础。
在11年期间对456名儿童的连续队列进行全外显子组测序(WES)。系统收集、分析并全面比较临床和遗传数据。
平均年龄为4.2岁,男女比例为2.2。在141名儿童中鉴定出16个基因中的260个致病变异,分子诊断阳性率为31%。在这些致病变异中,43%是新发现的。最常见的诊断是原发性高草酸尿症(PH)(1型:20%,2型:11%,3型:24%)和胱氨酸尿症(A型:18%,B型:14%)。分子诊断阳性的儿童更有可能出现结石发作、双侧结石、多发结石或肾钙质沉着症(均P<0.05)。有ATP6V0A4缺陷的儿童更容易出现严重的临床表现,而有CLCNKB缺陷的儿童以及有SLC3A1和CLCNKB缺陷的男性往往在较年轻的年龄被诊断出来。疑似临床诊断与分子诊断之间的符合率为81%。至少29%的儿童可从基于分子诊断的额外临床建议中受益。
在中国队列中,456例肾结石儿科患者中有141例(31%)确定了遗传病因。分子诊断阳性是儿童肾结石严重临床表现的一个危险因素。WES有潜力用于确认甚至修正临床诊断,从而促进个体化的治疗和预防干预。